AI assistant
Sending…
Cardlytics, Inc. — Director's Dealing 2020
Mar 25, 2020
33956_dirs_2020-03-25_d0b6b5a3-6a88-4405-b4d1-150a7c7cc534.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cardlytics, Inc. (CDLX)
CIK: 0001666071
Period of Report: 2020-03-23
Reporting Person: Grimes Scott D. (Director, Chief Executive Officer, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-03-23 | Common Stock | S | 1000 | $30.52 | Disposed | 137112 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 389431 | Direct |
Footnotes
F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the 2013 Scott Grimes GRAT UAD (the "GRAT") on November 15, 2019.
F2: The reportable securities are held by the GRAT.
More from Cardlytics, Inc.
Delisting Announcement
2026
Jun 3
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 9
Proxy Solicitation & Information Statement
2026
Apr 9
Annual Report
2026
Mar 4
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 19